Journals in Oncology

Cancer Treatment Reviews

ISSN: 0305-7372
5 Year impact factor: 10.9
Impact factor: 9.6

Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterJournal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.

Subscriptions

Cancer Treatment and Research Communications

ISSN: 2213-0896

Cancer Treatment and Research Communications is an international peer-reviewed journal dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches in all tumor types; cancer biology; molecular carcinogenesis; cancer genetics and genomics; cancer stem cells; molecular and cellular oncology; systems biology; immuno-oncology; chemoprevention strategies; gene and antisense therapy; the pathology of cancer, prognostic and predictive markers; drug sensitivity and resistance and novel treatment strategies to impact patient care. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials.Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice. Peer reviewed types of articles include Original Reports, Reviews and Editorials. The journal will not consider Case Reports or articles related to Cancer Policy.

Subscriptions

Cancer Treatment and Research Communications

ISSN: 2468-2942

Subscriptions

Cellular Signalling

ISSN: 0898-6568
5 Year impact factor: 4.4
Impact factor: 4.4

Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.

Subscriptions

Clinical Breast Cancer

ISSN: 1526-8209
5 Year impact factor: 2.8
Impact factor: 2.9

Clinical Breast Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Publishing eight issues per year, Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Clinical Colorectal Cancer

ISSN: 1533-0028
5 Year impact factor: 3.1
Impact factor: 3.3

Clinical Colorectal Cancer is devoted to manuscripts that focus on early detection/screening, diagnosis, prevention, and treatment of colorectal cancer and other GI cancers, including pancreatic, liver, gastric/gastroesopha... biliary, and other gastrointestinal cancers. The major emphasis is on recent scientific developments and original peer-reviewed manuscripts. Specific areas of interest include original reports on clinical research and/or translational research and translational correlative science that is directly related to clinical trials, in all (multidisciplinary) therapeutic fields that relate to colorectal cancer and other GI cancers.Further areas of interest include original research on drug sensitivity and resistance to cytotoxic agents, targeted therapies, immunotherapies, and other novel therapeutic approaches; pathology, (validated) predictive markers, and prognostic indicators; chemoprevention strategies; and integration of various therapeutic and multidisciplinary approaches. A much lower priority will be given to meta-analyses, pooled analyses, and real-world analyses unless the knowledge gained from such reports is significant and can be applied to clinical practice. In addition, unsolicited reviews are not encouraged unless there has been a discussion with the editor or deputy editors as the journal wants to ensure that reviews will provide real added value and true gain of knowledge.

Subscriptions

Clinical Genitourinary Cancer

ISSN: 1558-7673
5 Year impact factor: 2.3
Impact factor: 2.3

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Clinical Lung Cancer

ISSN: 1525-7304
5 Year impact factor: 3.4
Impact factor: 3.3

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Clinical Lymphoma, Myeloma & Leukemia

ISSN: 2152-2650
5 Year impact factor: 2.4
Impact factor: 2.7

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Clinical Oncology

ISSN: 0936-6555
5 Year impact factor: 3.3
Impact factor: 3.2

Clinical Oncology is essential reading for all those with an active interest in the treatment of cancer. Its multidisciplinary approach allows readers to keep up-to-date with developments in their own as well as related fields.Each issue is carefully selected to provide a combination of high quality original research, informative editorials and state-of-the-art reviews. The Journal covers all aspects of the clinical management of cancer patients and its authors are drawn from leading international centres.The Journal features papers on all types of malignant disease including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment.

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Oncology

Cancer Treatment Reviews

Cancer Treatment and Research Communications

Cancer Treatment and Research Communications

Cellular Signalling

Clinical Breast Cancer

Clinical Colorectal Cancer

Clinical Genitourinary Cancer

Clinical Lung Cancer

Clinical Lymphoma, Myeloma & Leukemia

Clinical Oncology